Etiket: Valneva
Vaccine stocks in sight: Valneva with blockbuster hope
shares in this article by Julia Groß, Euro am Sonntag Valneva, together with partner Pfizer, has started a phase 3 trial of Lyme disease vaccine VLA15. 6,000 participants aged…
Vaccine stock Valneva: Big gain thanks to Pfizer
shares in this article ETFs in this article by Julia Gro, Euro on Sunday Valneva is making the headlines again: The US pharmaceutical group Pfizer is investing EUR 90.5…
Valneva Stock: Valneva Criticizes EU Vaccine Program Before Expiration?
shares in this article “In March we received a list of questions from the EMA, which we answered and submitted immediately. At the time, we expected approval in April 2022.…
Valneva share plummeting: Setback for Valneva inactivated vaccine – EU authority demands more information
shares in this article The European Medicines Agency (EMA) has requested more information about the vaccine, the company said on Monday. So far, the company hoped to get approval for…
BioNTech, Moderna and Valneva: Sentiment on vaccine stocks is brightening
shares in this article ETFs in this article by Julia Gro, Euro on Sunday DThe disturbing news about the sharp rise in corona cases in China has caused shares…
Valneva, BioNTech & Co: Vaccine Stocks – Risk Aversion
shares in this article by Julia Gro, Euro on Sunday Dhe war has prompted stock markets to flee risky investments, including biotech stocks. Valneva bucked the trend with positive…